María Isolina
Santiago Pérez
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (6)
2024
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828
-
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
Pediatric Allergy and Immunology, Vol. 35, Núm. 5
2023
-
Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020
Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 305-310
2022
-
Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool
Journal of Clinical Epidemiology, Vol. 147, pp. 101-110
-
Serum cotinine cut-points for secondhand smoke exposure assessment in children under 5 years: A systemic review
PLoS ONE, Vol. 17, Núm. 5 May